Higher CEA levels in patients with colorectal cancer are indicative of aggressive tumour phenotypes and survival Evidence ...

“Our new biochip device is low-cost — just a few dollars — and sensitive, which will make accurate disease diagnosis ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

Researchers reveal how a new breakthrough could make early cancer detection more accessible and affordable worldwide.

Six targets for multiple fragments (CD20, CD22, carcinoembryonic antigen (CEA), EpCAM, HER2/Neu and Lewis Y) are also common targets for full-length anticancer mAbs 35; for example, EpCAM has been ...

Carcinoembryonic antigen; QD: Quantum dot. This work has been funded by a grant from Yousef Jameel (YJ-Science & Technology Research Center, The American University in Cairo) to H Azzazy.

In contrast, tests involving other cancer markers, such as carcinoembryonic antigen and carbohydrate antigen 19-9, generally cannot reach the high sensitivity needed for catching early-stage cancers.

Adagene (ADAG) announced data at the SITC 39th Annual Meeting, taking place in Houston, Nov. 6 – 10, 2024. The two poster presentations ...

such as bile cytology and bile carcinoembryonic antigen (CEA) levels, and dual phase CT or magnetic resonance (MR) sequences should be obtained before a confident diagnosis is made. [14] To ...

Pancreaticobiliary cytopathology has emerged as a critical diagnostic tool, especially in evaluating pancreatic and bile duct lesions. Traditionally ...

The following is a summary of the study "Lipid levels and insulin resistance markers in gastric cancer patients: diagnostic and prognostic significance," published in the October 2024 issue of ...